Back to Journals » OncoTargets and Therapy » Volume 12

Review

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies

       
Total article views   HTML views PDF downloads Totals
31,889 Dovepress* 11,298+ 2,036 13,334
PubMed Central* 20,591 2,272 22,863
Totals 31,889 4,308 36,197
*Since 18 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on PubMed Central and Google Scholar